Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May;34(5):1053-1066.
doi: 10.1007/s11095-017-2123-5. Epub 2017 Mar 17.

Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading

Affiliations
Review

Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading

Dhruvitkumar S Sutaria et al. Pharm Res. 2017 May.

Abstract

Extracellular vesicles (EVs) represent a class of cell secreted organelles which naturally contain biomolecular cargo such as miRNA, mRNA and proteins. EVs mediate intercellular communication, enabling the transfer of functional nucleic acids from the cell of origin to the recipient cells. In addition, EVs make an attractive delivery vehicle for therapeutics owing to their increased stability in circulation, biocompatibility, low immunogenicity and toxicity profiles. EVs can also be engineered to display targeting moieties on their surfaces which enables targeting to desired tissues, organs or cells. While much has been learned on the role of EVs as cell communicators, the field of therapeutic EV application is currently under development. Critical to the future success of EV delivery system is the description of methods by which therapeutics can be successfully and efficiently loaded within the EVs. Two methods of loading of EVs with therapeutic cargo exist, endogenous and exogenous loading. We have therefore focused this review on describing the various published approaches for loading EVs with therapeutics.

Keywords: EV therapeutics; drug loading; exosomes; extracellular vesicles; microvesicles.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Biogenesis of Extracellular vesicles. Exosome biogenesis begins with the invagination of the plasma membrane followed by the inward budding of the endosome to form multivesicular bodies (MVBs) which then fuse with the plasma membrane to release these smaller types of EVs. Microvesicles on the other hand are formed directly by the outward budding of the plasma membrane.
Figure 2
Figure 2
Different approaches to load EV therapeutics. EVs could be therapeutically loaded using endogenous and exogenous loading techniques. Endogenous approach involves overexpressing therapeutic cargo within the donor cells, which eventually gets loaded within the EVs. Exogenous approach includes the loading of therapeutic cargo within EVs once they are isolated. Depending upon the specific loading technique through which the cargo is loaded inside of the EVs, they could be further sub-classified into active and passive loading.

References

    1. Pan BT, Johnstone RM. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell. 1983;33(3):967–78. - PubMed
    1. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654–9. - PubMed
    1. Kalra H, Simpson RJ, Ji H, Aikawa E, Altevogt P, Askenase P, et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 2012;10(12):e1001450. - PMC - PubMed
    1. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE. 2008;3(11):e3694. - PMC - PubMed
    1. Kogure T, Yan IK, Lin WL, Patel T. Extracellular Vesicle-Mediated Transfer of a Novel Long Noncoding RNA TUC339: A Mechanism of Intercellular Signaling in Human Hepatocellular Cancer. Genes & cancer. 2013;4(7–8):261–72. - PMC - PubMed

Publication types

Substances